The Western Australian COVID-19 Immunity Collaborative (WACIC) Biobank: a prospective bio repository of specimens and clinical data to enable research and development of diagnostic assays relevant to SARS-CoV-2 immunity.
Mackenzie's Mission: The Australian Reproductive Carrier Screening Project
This study will investigate reproductive genetic carrier screening (RGCS) in 10,000 couples across Australia. Carrier screening for approximately 1300 genes associated with severe, childhood-onset, X-linked and autosomal recessive conditions will be performed on each member of the couple. A combined result will be issued indicating whether the couple has a 'low' or 'increased' risk of having a child with a genetic condition. It is anticipated that 1-2% of couples will be at an increased risk of having an affected child.
The study will evaluate all aspects of the RGCS program to assess the feasibility and acceptability of a publicly-funded population-wide RGCS program, including:
education of recruiting healthcare providers
education of participating couples
implementation and uptake of RGCS
frequency of increased-risk couples and their reproductive decisions
psychosocial impacts
ethical issues
health economic implications
health implementation research
Efficacy of mindfulness based cognitive therapy for the treatment of depression in idiopathic Parkinson's disease.
100 Clinical Results associated with Fremantle Hospital & Health Service (Australia)
0 Patents (Medical) associated with Fremantle Hospital & Health Service (Australia)
100 Deals associated with Fremantle Hospital & Health Service (Australia)
100 Translational Medicine associated with Fremantle Hospital & Health Service (Australia)